Stable disease and improved health-related quality of life (HRQoL) following fractionated low dose 131I-metaiodobenzyl-guanidine (MIBG) therapy in metastatic paediatric paragan-glioma: observation of false “reverse” discordance during pre-therapy work up and its implication for patient selection for high dose targeted therapy

Simple item page
dc.contributor.authorBasu, Sandip
dc.contributor.authorNair, Narendra
dc.date.accessioned2007-09-26T09:19:29Z
dc.date.available2007-09-26T09:19:29Z
dc.date.issued2006
dc.format.extent4789 bytes
dc.format.mimetypetext/html
dc.identifier.urihttp://hdl.handle.net/123456789/742
dc.language.isoenen
dc.subjectlow doseen
dc.subject131I-metaiodobenzyl-guanidineen
dc.subjectmetastatic paediatric paragan-gliomaen
dc.titleStable disease and improved health-related quality of life (HRQoL) following fractionated low dose 131I-metaiodobenzyl-guanidine (MIBG) therapy in metastatic paediatric paragan-glioma: observation of false “reverse” discordance during pre-therapy work up and its implication for patient selection for high dose targeted therapyen
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0572.html
Size:
4.68 KB
Format:
Hypertext Markup Language
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

2006